É. Rouveix
- Virology top 5%
- HIV Research and Treatment 14
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 20
- HIV/AIDS drug development and treatment 11
- Hepatology top 5%
- Epidemiology top 10%
- Infective Endocarditis Diagnosis and Management 9
- HIV, Drug Use, Sexual Risk 9
- Pneumocystis jirovecii pneumonia detection and treatment 7
-
- HIV-related health complications and treatments 4
-
- Vaccine Coverage and Hesitancy 4
- Co-authors
- B. RégnierS WitchitzF FraisseCaroline DupontDominique CostagliolaPierre de TruchisAlain BeauchetPhilippe Aegerter
- Journals
- AIDS (4 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
É. Rouveix
71 papers receiving 902 citations
Peers
Comparison fields: 5 of 90
- Virology 184
- Infectious Diseases 464
- Hepatology 122
- Epidemiology 458
- Applied Microbiology and Biotechnology 26
Countries citing papers authored by É. Rouveix
This map shows the geographic impact of É. Rouveix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Rouveix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Rouveix more than expected).
Fields of papers citing papers by É. Rouveix
This network shows the impact of papers produced by É. Rouveix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Rouveix. The network helps show where É. Rouveix may publish in the future.
Co-authorship network
The 25 scholars most cited alongside É. Rouveix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 8 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 2 | |
| 5 | 2020 | 2 | |
| 6 | 2017 | 9 | |
| 7 | 2016 | 4 | |
| 8 | 2016 | 7 | |
| 9 | 2013 | 2 | |
| 10 | 2013 | 49 | |
| 11 | 2012 | 11 | |
| 12 | Family nutritional support improves survival, immune restoration and adherence in HIV patients receiving ART in developing country. | 2010 | 34 |
| 13 | 2009 | 12 | |
| 14 | 2007 | 12 | |
| 15 | 2006 | 14 | |
| 16 | 2006 | 103 | |
| 17 | 2002 | 6 | |
| 18 | Neurotoxicité à la sulfasalazine | 2001 | 2 |
| 19 | 2000 | 87 | |
| 20 | 1997 | 4 |
About É. Rouveix
É. Rouveix is a scholar working on Virology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 77 papers that have together received 948 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (20 papers), HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers), Infective Endocarditis Diagnosis and Management (9 papers), HIV, Drug Use, Sexual Risk (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), HIV-related health complications and treatments (4 papers) and Vaccine Coverage and Hesitancy (4 papers). The work is most often cited by research in Virology (184 citations), Infectious Diseases (464 citations) and Hepatology (122 citations). É. Rouveix has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include B. Régnier, S Witchitz, F Fraisse, Caroline Dupont, Dominique Costagliola, Pierre de Truchis, Alain Beauchet, Philippe Aegerter, D. Zucman and Marie‐Laure Chaix. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases, Journal of Clinical Virology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.